Retrospective Evaluation of Clinical Performance of the Astra Tech Implant System EV When Used in Everyday Practice

NCT ID: NCT03845738

Last Updated: 2024-03-18

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

208 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-08-12

Study Completion Date

2020-12-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is designed as a retrospective, multi-center study. The study population consist of subjects who received one or more OsseoSpeed EV implants during the period January 1st 2015 to December 31st 2016. Two hundred subjects will be enrolled, approximately 25-30 subjects per site. The study includes retrospective data collection from subjects' medical records and data collection from one prospective study visit with a clinical examination.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dental Implants

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

OsseoSpeed EV implant

The investigational product (OsseoSpeed EV implant) is already included in a restoration in the subject at enrollment, thus this study does not involve the installation of any investigational products.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject ≥ 18 years at time of implant installation.
* Subject signed and dated the informed consent form.
* Having installed one or more OsseoSpeed EV implants between January 1st 2015 and December 31st 2016.

Exclusion Criteria

* Unlikely to be able to comply with study procedures, according to Investigator's judgement.
* Subject is not willing to participate in the study or not able to understand the content of the study.
* Involvement in the planning or conduct of the study.
* Simultaneous participation in another clinical study that may interfere with the present study.
* Severe non-compliance to Clinical Investigation Plan (CIP) as judged by the Investigator and/or Dentsply Sirona Implants.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Dentsply Sirona Implants and Consumables

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stijn Vervaeke, MD

Role: PRINCIPAL_INVESTIGATOR

Centrum voor tandheelkunde Geluwe, Belgium

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Illinois College of Dentistry

Chicago, Illinois, United States

Site Status

Centrum voor tandheelkunde Geluwe

Geluwe, , Belgium

Site Status

Burlington Prosthodontics

Burlington, , Canada

Site Status

Oral Hammaslääkärit

Helsinki, , Finland

Site Status

Implantarium Gernsbach

Gernsbach, , Germany

Site Status

Universitätsklinik Heidelberg, Klinik und Poliklinik für Mund-, Kiefer- und Gesichtschirurgie

Heidelberg, , Germany

Site Status

Hallands sjukhus Halmstad, Department of Oral & Maxillofacial surgery

Halmstad, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Belgium Canada Finland Germany Sweden

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

C-AS-18-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.